Latest News

Amgen Agrees to Deal to Buy Horizon Therapeutics

Horizon develops medicines to treat rare autoimmune and severe inflammatory diseases.Photo: Artur Widak/Zuma Press

Amgen Inc. has agreed to acquire Horizon Therapeutics PLC in an all-cash deal valued at $27.8 billion, marking the largest healthcare merger of the year.

Under the terms of the deal, which was first reported by The Wall Street Journal, Amgen will pay $116.50 for each Horizon share owned. The offer was equal to a premium of 19.7% over the stock’s closing price Friday at $97.29.

Already a member? Sign In

Most Popular news

Most Popular opinion

Recommended Videos

Crypto: Bieber, Madonna, Steph Curry, Snoop Dogg in Big Trouble

Previous article

Suze Orman: If you think you’re ready for retirement, think again — 5 moves to keep you out of the poorhouse

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News